Mike has 30 years global Health industry experience and among other roles is currently Executive Chair of iPlato and the #1 medical app myGP, the GP to Patient mHealth platform with 21 million registered users in the UK, and Chair of Cambridge Cognition plc, the neuro-psychological, diagnostics company.
Previously he held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (New Jersey), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn public to private buyout. After spending 22 of the last 26 years living and working outside the UK, Mike now works with UK based companies.
Mike also Chairs the Assisted Living Innovation Platform, is the Chair of the Biocatalyst Major Awards Panel, Chairs the KTN MedTech Board and also acts as healthcare advisor for multiple private equity companies.
With a background spanning pharma to dental and biotech to medical devices and now diagnostics to digital, I will bring an understanding of how life sciences fits into the UK. From my International work, living and working outside the UK, I understand how different health systems work from a provider and payor perspective.
I have been part of 2 IPOs in New York and London plus 1 LMBO in Sweden and over 25 transactions within the healthcare space. I have been involved with and now Chair the Biomedical Catalyst grant body for the MRC and Innovate, where we fund £30-50m of innovations per year. In addition, I Chair the KTN Life Science group with representatives from all devolved governments, NICE, MHRA etc. The largest organization I led was $2bn turnover with 7500 staff and now I work with start-ups where I take an active role and involvement.
In summary, I bring International, Industry breadth, Government work, Scale, Investment climate and Insight.